Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05563051 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Kaneka Endovascular Embolization and Protection

Study acronym: KEEP
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 7, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Oct 2024 to Dec 2025
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Oct 2025 to Dec 2025
    • Site details revised at 4 of 4 sites
    v5
  2. Re-verified, no change to tracked fieldsv4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 4
    • Start date changed from estimate of Oct 2022 to Dec 13, 2022
    v3
  4. Secondary endpoints revised (5)v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Prospective, multi-center, non-randomized registry / study, up to 164 patients enrolled and followed at 180 days +/- 45 days and again at 365 days +/- 90 days post procedure
Trial Details
NCT Number NCT05563051
Lead Sponsor Kaneka Medical America LLC
Conditions
(from sponsor)		 Aneurysm Cerebral
Related terms Aneurysm, Intracranial Aneurysm
Enrollment 164 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov